Expression of BHRF1 improves survival of murine hybridoma cultures in batch and continuous modes |
| |
Authors: | Sandra Juanola Joaquim Vives Ernest Milián Eva Prats Jordi J Cairó Francesc Gòdia |
| |
Institution: | (1) Departament d’Enginyeria Química, Escola Tècnica Superior d’Enginyeria (ETSE), Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain;(2) Departament de Biologia Molecular i Cellular, IBMB-CSIC, Jordi Girona 18-26, 08034 Barcelona, Spain |
| |
Abstract: | Cell death by apoptosis limits growth and productivity in most animal cell cultures. It is therefore desirable to define genetic
interventions to generate robust cell lines with superior performance in bioreactors, either by increasing specific productivity,
life-span of the cultures or both. In this context, forced expression of BHRF1, an Epstein–Barr virus-encoded early protein
with structural and functional homology with the anti-apoptotic protein Bcl-2, effectively protected hybridomas in culture
and delayed cell death under conditions of glutamine starvation. In the present study, we explored the potential application
of BHRF1 expression in hybridomas for long-term apoptosis protection under different biotechnological process designs (batch
and continuous) and compared it to strategies based on Bcl-2 overexpression. Our results confirmed that long-term maintenance
of the anti-apoptotic effect of BHRF1 can be obtained using bicistronic configurations conferring enhanced protection compared
to Bcl-2, even in the absence of selective pressure. Such protective effect of BHRF1 is demonstrated both in batch and continuous
culture. Moreover, a further analysis at high cell densities in semi-continuous perfusion cultures indicated that the mechanism
of action of BHRF1 involves cell cycle arrest in G0–G1 state and this is translated in lower numbers of dead cells. |
| |
Keywords: | BHRF1 Hybridoma cells Apoptosis protection |
本文献已被 SpringerLink 等数据库收录! |
|